Healthcare provider profile · identity verified

Ailey Brehmer, DO

Internal Medicine · WEST DES MOINES, IA · NPI 1104939545

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	536	144
Atorvastatin Calcium	Atorvastatin Calcium	500	159
Amlodipine Besylate	Amlodipine Besylate	321	84
Omeprazole	Omeprazole	314	92
Losartan Potassium	Losartan Potassium	298	80
Lisinopril	Lisinopril	261	83
Simvastatin	Simvastatin	237	65
Escitalopram Oxalate	Escitalopram Oxalate	213	57
Tramadol Hcl	Tramadol Hcl	211	50
Hydrochlorothiazide	Hydrochlorothiazide	209	61
Pantoprazole Sodium	Pantoprazole Sodium	197	54
Gabapentin	Gabapentin	194	67
Ozempic	Semaglutide	190	33
Metoprolol Succinate	Metoprolol Succinate	170	51
Furosemide	Furosemide	149	48
Rosuvastatin Calcium	Rosuvastatin Calcium	140	45
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	137	36
Sertraline Hcl	Sertraline Hcl	125	38
Pravastatin Sodium	Pravastatin Sodium	124	34
Potassium Chloride	Potassium Chloride	121	29
Lorazepam	Lorazepam	119	43
Metformin Hcl	Metformin Hcl	117	38
Zolpidem Tartrate	Zolpidem Tartrate	111	30
Trazodone Hcl	Trazodone Hcl	105	34
Prednisone	Prednisone	103	57
Alprazolam	Alprazolam	100	23
Fluoxetine Hcl	Fluoxetine Hcl	97	24
Clonazepam	Clonazepam	95	17
Eliquis	Apixaban	89	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	86	19
Cephalexin	Cephalexin	85	57
Mounjaro	Tirzepatide	82	11
Venlafaxine Hcl Er	Venlafaxine Hcl	82	18
Atenolol	Atenolol	80	23
Montelukast Sodium	Montelukast Sodium	79	22
Bupropion Xl	Bupropion Hcl	76	22
Mirtazapine	Mirtazapine	76	21
Citalopram Hbr	Citalopram Hydrobromide	75	23
Tamsulosin Hcl	Tamsulosin Hcl	74	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	72	16
Metoprolol Tartrate	Metoprolol Tartrate	71	24
Allopurinol	Allopurinol	70	17
Alendronate Sodium	Alendronate Sodium	67	19
Meloxicam	Meloxicam	65	23
Donepezil Hcl	Donepezil Hcl	64	17
Trulicity	Dulaglutide	64	14
Xarelto	Rivaroxaban	64	18
Jardiance	Empagliflozin	63	14
Metformin Hcl Er	Metformin Hcl	63	23
Albuterol Sulfate Hfa	Albuterol Sulfate	60	31
Duloxetine Hcl	Duloxetine Hcl	58	15
Oxycodone Hcl	Oxycodone Hcl	57	11
Fluticasone Propionate	Fluticasone Propionate	56	18
Linzess	Linaclotide	56	14
Spironolactone	Spironolactone	54	17
Glipizide Er	Glipizide	53	13
Clopidogrel	Clopidogrel Bisulfate	52	16
Hydroxyzine Hcl	Hydroxyzine Hcl	50	19
Fluconazole	Fluconazole	49	26
Azithromycin	Azithromycin	47	39
Carvedilol	Carvedilol	45	15
Ezetimibe	Ezetimibe	44	12
Celecoxib	Celecoxib	43	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	41	12
Fentanyl	Fentanyl	41	suppressed
Tizanidine Hcl	Tizanidine Hcl	41	11
Buspirone Hcl	Buspirone Hcl	39	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Morphine Sulfate Er	Morphine Sulfate	38	suppressed
Famotidine	Famotidine	37	14
Ondansetron Odt	Ondansetron	36	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Synthroid	Levothyroxine Sodium	35	12
Memantine Hcl	Memantine Hcl	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	11
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Estradiol	Estradiol	32	16
Valacyclovir	Valacyclovir Hcl	32	20
Doxycycline Hyclate	Doxycycline Hyclate	31	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	24
Nitroglycerin	Nitroglycerin	30	suppressed
Nystatin	Nystatin	30	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	11
Benazepril Hcl	Benazepril Hcl	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	27
Glimepiride	Glimepiride	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	27	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	23
Lansoprazole	Lansoprazole	25	suppressed
Methylprednisolone	Methylprednisolone	24	21
Dulera	Mometasone/Formoterol	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	15
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Glipizide	Glipizide	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Naproxen	Naproxen	18	suppressed
Diazepam	Diazepam	17	suppressed
Baclofen	Baclofen	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	16	suppressed
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Nabumetone	Nabumetone	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Finasteride	Finasteride	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error